Whether early membranous nephropathy is good treatment varies from person to person. Generally speaking, patients with low proteinuria and normal renal function at the time of diagnosis are usually well treated; patients with persistent massive proteinuria, reduced renal function at the time of diagnosis, combined with renal tubular atrophy, renal interstitial fibrosis and other pathological manifestations are usually not well treated.
Membranous nephropathy is the main cause of adult nephrotic syndrome, which is antibody-mediated, characterized by immune complex deposition on the epithelial side of the glomerulus, causing sublethal injury to the podocytes and disruption of the glomerular filtration barrier, which ultimately leads to proteinuria and other manifestations of nephrotic syndrome.
The natural course of membranous nephropathy is unpredictable. Patients with less proteinuria, normal renal function at the time of consultation, and milder pathological manifestations have better treatment results and better prognosis; on the contrary, patients with persistent massive proteinuria, abnormal renal function at the time of consultation, and combined with renal tubular atrophy, renal interstitial fibrosis and other pathological manifestations have poorer treatment results and poorer prognosis.
Patients with early membranous nephropathy should go to the hospital in time and be treated under the guidance of professional physicians.